95 related articles for article (PubMed ID: 24578469)
1. Soluble Flt-1 release response to heparin use: implications for dialysis patients?
Di Marco GS; Pavenstädt H; Brand M
Nephrol Dial Transplant; 2014 Jun; 29(6):1112-5. PubMed ID: 24578469
[No Abstract] [Full Text] [Related]
2. Heparin use during dialysis sessions induces an increase in the antiangiogenic factor soluble Flt1.
Lavainne F; Meffray E; Pepper RJ; Néel M; Delcroix C; Salama AD; Fakhouri F
Nephrol Dial Transplant; 2014 Jun; 29(6):1225-31. PubMed ID: 24516233
[TBL] [Abstract][Full Text] [Related]
3. Suppressed soluble Fms-like tyrosine kinase-1 production aggravates atherosclerosis in chronic kidney disease.
Matsui M; Takeda Y; Uemura S; Matsumoto T; Seno A; Onoue K; Tsushima H; Morimoto K; Soeda T; Okayama S; Somekawa S; Samejima K; Kawata H; Kawakami R; Nakatani K; Iwano M; Saito Y
Kidney Int; 2014 Feb; 85(2):393-403. PubMed ID: 24048373
[TBL] [Abstract][Full Text] [Related]
4. Heparin therapy in routine hemodialysis.
Pittard JD
Nephrol News Issues; 2001 Apr; 15(5):73-5. PubMed ID: 12108969
[No Abstract] [Full Text] [Related]
5. Unfractionated heparin but not enoxaparin causes delayed plasma PAI-1 depletion in hemodialysis patients: a prospective study.
Naumnik B; Pawlak K; Mys'liwiec M
Clin Appl Thromb Hemost; 2009 Feb; 15(1):84-91. PubMed ID: 17895513
[TBL] [Abstract][Full Text] [Related]
6. Effect of an anticoagulant (heparin versus nafamostat mesilate) on the extrinsic coagulation pathway in chronic hemodialysis.
Matsuo T; Matsuo M; Kario K; Koide M
Blood Coagul Fibrinolysis; 1998 Jun; 9(4):391-3. PubMed ID: 9690813
[No Abstract] [Full Text] [Related]
7. Circulating vascular endothelial growth factor (VEGF) and its soluble receptor 1 (sVEGFR-1) are associated with inflammation and mortality in incident dialysis patients.
Yuan J; Guo Q; Qureshi AR; Anderstam B; Eriksson M; Heimbürger O; Bárány P; Stenvinkel P; Lindholm B
Nephrol Dial Transplant; 2013 Sep; 28(9):2356-63. PubMed ID: 23828162
[TBL] [Abstract][Full Text] [Related]
8. An evaluation of four modes of low-dose anticoagulation during intermittent haemodialysis.
Skagerlind MSE; Stegmayr BG
Eur J Clin Pharmacol; 2018 Mar; 74(3):267-274. PubMed ID: 29198062
[TBL] [Abstract][Full Text] [Related]
9. [Effect of heparin on desmofibrin-generating activity of the blood in patients with chronic kidney failure treated with hemodialysis].
Zuch A; Chmielewska J; Poplawski A
Pol Arch Med Wewn; 1977 Oct; 58(4):367-75. PubMed ID: 928176
[No Abstract] [Full Text] [Related]
10. The effect of r-hirudin vs. heparin on blood-membrane interactions during hemodialysis.
van Wyk V; Badenhorst PN; Kotzé HF
Clin Nephrol; 1997 Dec; 48(6):381-7. PubMed ID: 9438098
[TBL] [Abstract][Full Text] [Related]
11. Non anticoagulant effects of heparin: implications for animal models of peritoneal dialysis.
De Vriese AS; Mortier S; Lameire NH
Perit Dial Int; 2001; 21 Suppl 3():S354-6. PubMed ID: 11887853
[TBL] [Abstract][Full Text] [Related]
12. Regulation of vascular endothelial growth factor-A and its soluble receptor sFlt-1 by luteinizing hormone in vivo: implication for ovarian follicle angiogenesis.
Gutman G; Barak V; Maslovitz S; Amit A; Lessing JB; Geva E
Fertil Steril; 2008 Apr; 89(4):922-6. PubMed ID: 18343373
[TBL] [Abstract][Full Text] [Related]
13. Reciprocal changes in serum thyrotropin and free thyroxine produced by heparin.
Herschman JM; Jones CM; Bailey AL
J Clin Endocrinol Metab; 1972 Mar; 34(3):574-9. PubMed ID: 5011261
[No Abstract] [Full Text] [Related]
14. Haemodiafiltration elicits less platelet activation compared to haemodialysis.
Becs G; Hudák R; Fejes Z; Debreceni IB; Bhattoa HP; Balla J; Kappelmayer J
BMC Nephrol; 2016 Oct; 17(1):147. PubMed ID: 27737645
[TBL] [Abstract][Full Text] [Related]
15. High-normal platelet factor 4-heparin antibodies and mortality in hemodialysis patients.
Ringenberg R
Mayo Clin Proc; 2006 Feb; 81(2):263; author reply 263. PubMed ID: 16471084
[No Abstract] [Full Text] [Related]
16. [Prothrombin time in long-term hemodialyzed patients. The effect of a single hemodialysis, heparin, protamine and vitamin K].
Koslík S; Ponist J; Takác M; Lapsanská I
Cas Lek Cesk; 1983 Feb; 122(5):139-42. PubMed ID: 6831493
[No Abstract] [Full Text] [Related]
17. Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity.
He Y; Smith SK; Day KA; Clark DE; Licence DR; Charnock-Jones DS
Mol Endocrinol; 1999 Apr; 13(4):537-45. PubMed ID: 10194760
[TBL] [Abstract][Full Text] [Related]
18. Treatment of very preterm preeclampsia via heparin-mediated extracorporeal LDL-precipitation (H.E.L.P.) apheresis: The Freiburg preeclampsia H.E.L.P.-Apheresis study.
Winkler K; Contini C; König B; Krumrey B; Pütz G; Zschiedrich S; Pecks U; Stavropoulou D; Prömpeler H; Kunze M; Markfeld-Erol F
Pregnancy Hypertens; 2018 Apr; 12():136-143. PubMed ID: 29858106
[TBL] [Abstract][Full Text] [Related]
19. Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women.
Rajakumar A; Michael HM; Rajakumar PA; Shibata E; Hubel CA; Karumanchi SA; Thadhani R; Wolf M; Harger G; Markovic N
Placenta; 2005 Aug; 26(7):563-73. PubMed ID: 15993706
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte growth factor: a possible mediator of heparin-induced osteoporosis?
Borawski J; Naumnik B; Myśliwiec M
Clin Appl Thromb Hemost; 2003 Apr; 9(2):171-2. PubMed ID: 12812389
[No Abstract] [Full Text] [Related]
[Next] [New Search]
